Etheros Pharmaceuticals Corp.
New Filing
CIK: 0002005132·Pharmaceuticals·DELAWARE·Filed: Jun 10, 2025
Total Offering
$600,000
Amount Sold
$600,000
Investors
6
First Sale
Jan 31, 2025
Offering Details
- Type
- Other: Simple agreement for future equity (SAFE)
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2022
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| John William Scannell | Related Person |
| Marc Feldmann | Related Person |
| Laura Dugan | Related Person |
| Francis Knuettel II | Related Person |
| Subhasish Chakraborty | Related Person |
Company
SEC Filing
0001999371-25-007554
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free